دورية أكاديمية
أعرض في EDS

Hysteroscopic Endometrial Ablation: From Indications to Instrumentation and Techniques-A Call to Action.

التفاصيل البيبلوغرافية
العنوان: Hysteroscopic Endometrial Ablation: From Indications to Instrumentation and Techniques-A Call to Action.
المؤلفون: Vitale SG; Division of Gynecology and Obstetrics, Department of Surgical Sciences, University of Cagliari, 09124 Cagliari, Italy., Della Corte L; Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy., Ciebiera M; Second Department of Obstetrics and Gynecology, Center of Postgraduate Medical Education, 00189 Warsaw, Poland., Carugno J; Minimally Invasive Gynecology Unit, Obstetrics, Gynecology and Reproductive Sciences Department, Miller School of Medicine, University of Miami, Miami, FL 33136, USA., Riemma G; Obstetrics and Gynecology Unit, Department of Woman, Child and General and Specialized Surgery, University of Campania 'Luigi Vanvitelli', 80128 Naples, Italy., Lasmar RB; Department of Surgery and Specialities, Federal Fluminense University, Rio de Janeiro 24020-140, Brazil., Lasmar BP; Department of Surgery and Specialities, Federal Fluminense University, Rio de Janeiro 24020-140, Brazil., Kahramanoglu I; Department of Gynecologic Oncology, Emsey Hospital, 34912 Istanbul, Turkey., Urman B; Department of Obstetrics and Gynecology, Koc University School of Medicine, 34010 Istanbul, Turkey., Mikuš M; Department of Obstetrics and Gynecology, University Hospital Centre Zagreb, Petrova 13, 10000 Zagreb, Croatia., De Angelis C; Department of Maternal and Child Health and Urological Sciences, 'Sapienza' University of Rome, 00185 Rome, Italy., Török P; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary., Angioni S; Division of Gynecology and Obstetrics, Department of Surgical Sciences, University of Cagliari, 09124 Cagliari, Italy.
المصدر: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2023 Jan 17; Vol. 13 (3). Date of Electronic Publication: 2023 Jan 17.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101658402 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4418 (Print) Linking ISSN: 20754418 NLM ISO Abbreviation: Diagnostics (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, [2011]-
مستخلص: The development of minimally invasive techniques has led to the creation of innovative alternatives in cases where traditional methods are not applicable. In modern gynecology, hysteroscopy has become the gold standard for the evaluation and treatment of intrauterine pathology. Endometrial ablation (EA) is a procedure that uses different types of energy to destroy the endometrium and is currently used as an alternative technique in cases of heavy menstrual bleeding when medical treatment has failed and uterine preservation is desired. The aim of this review was to evaluate the feasibility, safety, and clinical outcomes of hysteroscopic EA as an alternative in patients with abnormal uterine bleeding. A detailed computerized search of the literature was performed in the main electronic databases (MEDLINE, EMBASE, Web of Science, PubMed, and Cochrane Library), from 1994 to June 2022, to evaluate the outcomes in patients with abnormal uterine bleeding (AUB) undergoing EA using hysteroscopic and non-hysteroscopic techniques. Only scientific publications in English were included. Twelve articles on the current use of endometrial ablation were included. Data on patient symptoms, tools used for EA, primary outcomes, and adverse events were recorded. EA should be considered an effective and safe approach in the management of patients with abnormal uterine bleeding caused by benign pathology, in whom medical treatment has failed or is contraindicated. Due to the lack of evidence, it would be interesting to determine whether EA would also have a role in the treatment of women with premalignant lesions, avoiding invasive surgical procedures or medical treatment in those patients for whom hysterectomy or the use of hormonal treatment is contraindicated.
References: Best Pract Res Clin Obstet Gynaecol. 2005 Aug;19(5):713-26. (PMID: 16023413)
Obstet Gynecol. 2000 Aug;96(2):266-70. (PMID: 10908775)
Biomed Res Int. 2017;2017:6848250. (PMID: 28948169)
Obstet Gynecol. 2014 Nov;124(5):904-910. (PMID: 25437717)
Climacteric. 2020 Aug;23(4):369-375. (PMID: 32368939)
J Minim Invasive Gynecol. 2013 Jul-Aug;20(4):487-91. (PMID: 23870238)
Int J Gynaecol Obstet. 2000 Dec;71(3):283-4. (PMID: 11102628)
J Am Assoc Gynecol Laparosc. 2004 Feb;11(1):59-61. (PMID: 15104833)
J Obstet Gynaecol Res. 2015 Dec;41(12):1935-41. (PMID: 26534903)
Curr Opin Obstet Gynecol. 2003 Aug;15(4):303-8. (PMID: 12858102)
Obstet Gynecol. 2017 Sep;130(3):554-560. (PMID: 28796675)
Diagnostics (Basel). 2022 May 09;12(5):. (PMID: 35626331)
Hum Reprod. 2001 Jan;16(1):168-171. (PMID: 11139557)
J Minim Invasive Gynecol. 2017 Nov - Dec;24(7):1104-1110. (PMID: 28843536)
Acta Obstet Gynecol Scand. 2009;88(2):227-30. (PMID: 19023681)
Obstet Gynecol Clin North Am. 2000 Jun;27(2):347-66. (PMID: 10857125)
J Minim Invasive Gynecol. 2013 Sep-Oct;20(5):642-7. (PMID: 23791400)
Minerva Ginecol. 2016 Dec;68(6):722-6. (PMID: 26954490)
BMJ Clin Evid. 2015 Sep 18;2015:. (PMID: 26382038)
J Am Assoc Gynecol Laparosc. 2003 Nov;10(4):491-5; discussion 495. (PMID: 14738636)
Clin Exp Obstet Gynecol. 2014;41(3):335-8. (PMID: 24992788)
Fam Pract. 2017 Nov 16;34(6):673-678. (PMID: 28586411)
Gynecol Surg. 2011 May;8(2):193-196. (PMID: 21654903)
Am J Obstet Gynecol. 2019 Dec;221(6):629.e1-629.e18. (PMID: 31310749)
Int J Gynecol Cancer. 2022 Jul 26;:. (PMID: 35882425)
J Minim Invasive Gynecol. 2010 May-Jun;17(3):344-50. (PMID: 20417426)
Minim Invasive Ther Allied Technol. 2021 Oct;30(5):288-295. (PMID: 34218728)
Eur J Gynaecol Oncol. 2002;23(2):151-3. (PMID: 12013114)
Acta Oncol. 2016;55(2):188-92. (PMID: 26243443)
Diagnostics (Basel). 2021 Mar 04;11(3):. (PMID: 33806571)
J Minim Invasive Gynecol. 2008 Jul-Aug;15(4):466-71. (PMID: 18588849)
Am J Obstet Gynecol. 2014 Nov;211(5):556.e1-6. (PMID: 25019488)
J Clin Med. 2020 Jul 03;9(7):. (PMID: 32635369)
Oman Med J. 2017 Nov;32(6):492-498. (PMID: 29218126)
Acta Obstet Gynecol Scand. 2007;86(4):480-3. (PMID: 17486472)
Circulation. 2019 Sep 10;140(11):e563-e595. (PMID: 30879339)
Hum Reprod. 2002 Nov;17(11):2795-806. (PMID: 12407030)
Minim Invasive Ther Allied Technol. 2021 Jun;30(3):147-153. (PMID: 31855088)
Fertil Steril. 2003 Jul;80(1):199-202. (PMID: 12849824)
J Minim Invasive Gynecol. 2010 Jul-Aug;17(4):436-48. (PMID: 20621007)
Eur J Obstet Gynecol Reprod Biol. 2016 Nov;206:32-35. (PMID: 27632410)
Fertil Steril. 2008 Feb;89(2):438-43. (PMID: 17482613)
Int J Gynaecol Obstet. 2011 Apr;113(1):3-13. (PMID: 21345435)
Updates Surg. 2020 Mar;72(1):213-218. (PMID: 31993995)
Int J Gynaecol Obstet. 2008 Apr;101(1):39-42. (PMID: 18078939)
Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):210-4. (PMID: 18248873)
Int J Gynaecol Obstet. 2022 Jan;156(1):112-118. (PMID: 33615469)
Fertil Steril. 2004 Nov;82(5):1395-401. (PMID: 15533366)
Gynecol Endocrinol. 2014 Feb;30(2):149-52. (PMID: 24303914)
J Minim Invasive Gynecol. 2020 Sep - Oct;27(6):1414-1416. (PMID: 31884079)
Fertil Steril. 2003 Feb;79(2):418-21. (PMID: 12568856)
Res Integr Peer Rev. 2019 Mar 26;4:5. (PMID: 30962953)
Womens Health (Lond). 2016 Jan;12(1):45-52. (PMID: 26756668)
Obstet Gynecol. 2003 Dec;102(6):1278-82. (PMID: 14662215)
J Minim Invasive Gynecol. 2015 Jul-Aug;22(5):792-8. (PMID: 25796220)
BJOG. 2011 Sep;118(10):1171-9. (PMID: 21624035)
Cochrane Database Syst Rev. 2002;(3):CD001124. (PMID: 12137619)
J Minim Invasive Gynecol. 2019 Sep - Oct;26(6):1169-1176. (PMID: 30528831)
Int J Gynaecol Obstet. 2021 Dec;155(3):425-432. (PMID: 33686708)
J Minim Invasive Gynecol. 2015 Nov-Dec;22(7):1225-30. (PMID: 26149205)
Hum Reprod. 2003 Nov;18(11):2441-5. (PMID: 14585898)
J Obstet Gynaecol Can. 2015 Apr;37(4):362-79. (PMID: 26001691)
Arch Gynecol Obstet. 2017 Jan;295(1):3-7. (PMID: 27834002)
Minerva Ginecol. 2016 Apr;68(2):143-53. (PMID: 26928420)
Ginekol Pol. 2018;89(7):398-404. (PMID: 30091451)
J Minim Invasive Gynecol. 2005 Jan-Feb;12(1):62-6. (PMID: 15904601)
Reprod Biomed Online. 2020 Jul;41(1):55-61. (PMID: 32444259)
Cochrane Database Syst Rev. 2003;(2):CD003855. (PMID: 12804492)
BJOG. 2013 Jul;120(8):966-70. (PMID: 23759085)
Am J Obstet Gynecol. 2022 Apr;226(4):487-498.e8. (PMID: 34555319)
BMJ. 1994 Oct 15;309(6960):979-83. (PMID: 7772106)
PLoS One. 2019 Jul 10;14(7):e0219294. (PMID: 31291298)
Rev Bras Ginecol Obstet. 2017 Jul;39(7):358-368. (PMID: 28605821)
Am J Obstet Gynecol. 2023 Jan;228(1):22-35.e2. (PMID: 35932873)
Expert Opin Drug Saf. 2022 Apr;21(4):477-486. (PMID: 34612122)
Gynecol Oncol. 2020 Aug;158(2):347-353. (PMID: 32467056)
J Minim Invasive Gynecol. 2021 Aug;28(8):1536-1543. (PMID: 33444791)
فهرسة مساهمة: Keywords: ablation; abnormal uterine bleeding; endometrial ablation; endometrium; heavy menstrual bleeding; hysterectomy; hysteroscopy; myoma; polyp; resectoscope
تواريخ الأحداث: Date Created: 20230211 Latest Revision: 20230213
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC9914843
DOI: 10.3390/diagnostics13030339
PMID: 36766443
قاعدة البيانات: MEDLINE
الوصف
تدمد:2075-4418
DOI:10.3390/diagnostics13030339